Human cord blood stem cell paracrine factors activate the survival protein kinase Akt and inhibit death protein kinases JNK and p38 in injured cardiomyocytes

Cytotherapy

Volumn 16, Issue 8, 2014, Pages 1158-1168

  Henning, Robert J ^a   Sanberg, Paul ^a   Jimenez, Ernesto ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Akt; Apoptosis; JNK; Myocytes; P38; Umbilical cord stem cells

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOGENIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOKINE; HYDROGEN PEROXIDE; INTERLEUKIN 10; PROTEIN KINASE B; SCATTER FACTOR; SOMATOMEDIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD; WESTERN BLOTTING; BIOSYNTHESIS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; GENETICS; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL SURVIVAL; ENZYME ACTIVATION; FETAL BLOOD; HUMANS; HYDROGEN PEROXIDE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE 4; MYOCYTES, CARDIAC; ONCOGENE PROTEIN V-AKT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARACRINE COMMUNICATION;

EID: 84903820819     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.01.415     Document Type: Article

References (59)

1. Lopez A.D., Murray C. The global burden of disease, 1990-2020. Nat Med 1998, 4:1241-1243.
2. Henning R.J. Stem cells in cardiac repair. Future Cardiol 2011, 7:99-117.
3. Henning R.J. Stem cells in cardiac repair: recent developments and future directions. Intervent Cardiol 2012, 7:10-14.
4. Henning R.J. Stem cells in cardiac repair: problems and possibilities. Future Cardiol 2013, 9:875-884.
5. Henning R.J., Abu-Ali H., Balis J.B., Morgan M., Willing A., Sanberg P. Human umbilical cord stem cells in the treatment of acute myocardial infarction. Cell Transplant 2004, 13:729-739.
6. Henning R.J., Burgos J.D., Ondrovic L., Sanberg P., Balis J., Morgan M. Human umbilical cord stem cells are attracted to myocardial infarctions. Cell Transplant 2006, 15:647-658.
7. Henning R.J., Burgos J.D., Vasko M., Alvarado F., Sanberg C., Sanberg P., et al. Human umbilical cord stem cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplant 2007, 16:907-917.
8. Henning R.J., Shariff M., Ujwala E., Alvarado F., Vasko M., Sanberg C., et al. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute infarcts. Stem Cells Dev 2008, 17:1207-1220.
9. Henning R.J., Aufman J., Shariff M., Sawmiller D., Delostia A., Sanberg P., et al. Human umbilical cord stem cells decrease fibrosis and increase cardiac function in cardiomyopathy. Regen Med 2010, 5:45-54.
10. Henning R.J., Dennis S., Sawmiller Hunter L., Sanberg P., Miller L. Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia. Transl Res 2012, 159:497-506.
11. Jin H., Sanberg P., Henning R.J. Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt. Cell Transplant 2013, 22:1637-1650.
12. Rose B., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010, 90:1507-1548.
13. Song Z., Ji X., Li X., Wang S., Wang S. Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury by suppressing JNK-mediated AIF translocation. JCell Mol Med 2008, 12:1220-1228.
14. Torcia M., De Chiara G., Nencioni L., Ammendola S., Labardi D., Lucibello M. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inhibition of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. JBiol Chem 2001, 276:39027-39036.
15. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., Schultz G. Morphological, biochemical and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991, 61:1476-1486.
16. Zordoky B., El-Kadi A. H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. JPharmacol Toxicol Methods 2007, 56:317-322.
17. Neufhoff S., Moers J., Ricks M., Grunwald T., Jensen A., Dermietzel R., et al. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp Hematol 2007, 35:1119-1131.
18. Chen N., Hudson J., Walczak P., Misiuta I., Garbuzova-Davis S., Jiang L., et al. Human umbilical cord blood progenitors. Stem Cells 2005, 23:1560-1570.
19. Lin Y., Huang R., Chen L., Lisoukov H., Lu Z., Li S., et al. Profiling of cytokine expression by biotin-labeled-based protein arrays. Proteomics 2003, 3:1750-1757.
20. Berndt N., Yang H., Trinczek B., Betzi S., Zhang Z., Wu B., et al. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ 2010, 17:1795-1804.
21. Kim D., Sun M., He L., Zhou Q., Sun X.-M., Bepler G., et al. Asmall molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. JBiol Chem 2010, 285:8383-8394.
22. Yang L., Dan H., Sun M., Liu Q., Sun X.-M., Feldman R., et al. Akt/Protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. JCancer Res 2004, 64:4394-4399.
23. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001, 98:13681-13686.
24. Remondino A., Kwon S., Communal C., Pimentel D., Sawyer D., Singh K., et al. β-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 2003, 92:136-138.
25. Mackay K., Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. JBiol Chem 1999, 274:6272-6279.
26. Liao P., Wang S.-Q., Wang S., Zheng M., Zheng M., Zhang S.-J. p38 mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res 2002, 90:190-196.
27. Gnecchi M., He H., Noiseux N., Liang O., Zhang L., Morello F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006, 20:661-669.
28. Kuboyama A., Tanaka S., Kawai K., Kasai H., Morii H., Tamae K., et al. 8-Hydroxyguanine levels and repair capacity during mouse embryonic stem cell differentiation. Free Radic Res 2011, 45:527-533.
29. Zhang J., Chen G., Wang Y., Zhao J., Duan H., Liao L., et al. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Chin Med J 2012, 125:3472-3478.
30. Sasaki K., Bannai S., Makino N. Kinetics of hydrogen peroxide elimination by human umbilical vein endothelial cells in culture. Biochim Biophys Acta 1998, 1380:275-288.
31. Sussman M., Volkers M., Fischer K., Bailey B., Cottage C., Din S., et al. Myocardial AKT: the omnipresent nexus. Physiol Rev 2011, 91:1023-1070.
32. Romashkova J., Makarov S. NF-kB is a target of Akt in antiapoptotic PDGF signaling. Nature 1999, 401:86-89.
33. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999, 96:857-868.
34. Pugazhenthi S., Nesterova A., Sable C., Heidenreich K., Boxer L., Heasley L., et al. Akt/Protein Kinase B upregulates bcl-2 expression through cAMP-responsive element binding protein. JBiol Chem 2000, 275:10761-10766.
35. Datta S., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to cell intrinsic death machinery. Cell 1997, 91:231-241.
36. Wang Y., Ahmad N., Wani M., Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. JMol Cell Cardiol 2004, 37:1041-1052.
37. Chen X.-H., Minatoguchi S., Kosai K. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. JCard Fail 2007, 13:874-883.
38. Rulxing Y., Dezhai Y., Hai W., Kai H. Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis. Eur J Heart Fail 2007, 9:343-351.
39. Li J., Leschka S., Rutschow S. Immunomodulation by IL-4. Eur J Pharmacol 2007, 554:60-68.
40. Jones S.P., Trocha S.D. IL-10 Cardioprotective actions are independent of iNOS. Am J Physiol Heart Circ Physiol 2001, 281:H48-H52.
41. Ito T., Ikeda U. Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2002, 2:257-263.
42. Hayward R., Nossuli T.O., Scalia R. Cardioprotective effect of IL-10. Eur J Pharmacol 1997, 334:157-163.
43. Lacraz S., Nicod L.P., Chicheportiche R. IL-10 inhibits metalloproteinase. JClin Invest 1995, 96:2304-2310.
44. Kajstura J., Bolli R., Sonnenblick E., Anversa P., Leri A. Cause of death: suicide. JMol Cell Cardiol 2006, 40:425-437.
45. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516.
46. Cerezo A., Martinez C., Lanzarot D., Fischer S., Franke T., Rebollo A. Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation. Mol Biol Cell 1998, 8:3107-3111.
47. Hreniuk D., Garay M., Gaarde W., Monia B., Mckay R., Cloffi C. Inhibition of C-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 2001, 59:867-874.
48. Kwon S., Pimentel D., Remondino A., Sawyer D., Colucci W. H2O2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. JMol Cell Cardiol 2003, 35:615-621.
49. Turner N., Xia F., Azhar G., Zhang X., Liu Z., Wei J. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2- terminal kinase pathway in H9c2 cardiac muscle cells. JMol Cell Cardiol 1998, 30:1789-1801.
50. Singh M., Sharma H., Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondria 2007, 7:367-373.
51. Aoki H., Kang P., Hampe J., Yoshimara K., Noma T., Matsuzki M., et al. Direct activation of mitochondrial apoptosis machinery by c-jun n-terminal kinase in adult cardiac myocytes. JBiol Chem 2002, 277:10244-10250.
52. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., et al. Requirement of JNK for stress induced activation of the cytochrome c-mediated death pathway. Science 2000, 288:870-874.
53. Yang D., Kuan C.-Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK gene. Nature 1997, 389:865-870.
54. Levresse V., Butterfield L., Zentrich E., Heasley L. Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. JNeurosci Res 2000, 62:799-808.
55. Wang Y., Huang S., Sah V., Ross J., Brown J., Han J., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. JBiol Chem 1998, 273:2161-2168.
56. Porras A., Zuluaga S., Black E., Valladares A., Alvarez A., Ambrosino C., et al. Mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 2004, 15:922-933.
57. Liao P., Georgakopoulos D., Kovacs A., Zheng M., Lerner D., Pu H., et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 2001, 98:12283-12288.
58. Ma X., Kuman S., Gao F., Louden C., Loprx B., Christopher T., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improve cardiac function after myocardial ischemia and reperfusion. Circulation 1999, 99:1685-1691.
59. Scneider S., Chen W., Hou J., Steenbergen C., Murphy E. Inhibition of p38 MAPK α/β reduces ischemic injury and does not block the protective effect of preconditioning. Am J Physiol Heart Circ Physiol 2001, 280:H499-H508.